The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...
For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...
Amgen also tested MariTide in a population with Type 2 diabetes, a group that tends to lose less weight with the new obesity ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...